Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioma × Minocycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

cyclopia sequence 8 Pain 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Sleepiness 1 Peripheral Nervous System Diseases 1 Parasomnias 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Hypesthesia 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Fatigue 1 Esophageal Neoplasms 1 Depression 1 Colorectal Neoplasms 1 Anxiety Disorders 1 Anorexia 1 Acute Pain 1

Interventions

Temozolomide 77 Bevacizumab 45 Radiotherapy 30 Irinotecan 19 Carboplatin 17 Magnetic Resonance Spectroscopy 16 Surgical Procedures, Operative 13 Carmustine 13 Radiation 9 Nivolumab 8 Erlotinib Hydrochloride 8 Thalidomide 7 Lomustine 7 Imatinib Mesylate 7 IL13-PE38 7 Everolimus 7 Aminolevulinic Acid 7 sargramostim 6 Topotecan 6 Radiotherapy, Intensity-Modulated 6 Cyclophosphamide 6 Chemotherapy, Adjuvant 6 vandetanib 5 fluorodopa F 18 5 Vincristine 5 Surveys and Questionnaires 5 Radiosurgery 5 Filgrastim 5 Blood Specimen Collection 5 temsirolimus 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01580969 2019-08-16

RAMBO

University of Utah

Phase 1/2 Completed

22 enrolled 18 charts

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡